About
Jointech-Med aims to create an intra-articular device designed to reduce intra-articular pressure, as well as continuous evacuation of inflammatory mediators from painful-effused knees in certain joint diseases. By reducing intra-articular pressure in joints suffering from diseases such as osteoarthritis and rheumatoid arthritis, pain will be decreased (by decreasing the capsular irritation caused by the increased pressure and inflammation), life quality will improve, and disease propagation (i.e. chondral destruction by the inflammatory process) might be decelerated (thus delaying the need for total joint arthroplasty). JoinTechs main focus is on patients that suffer from painful knee arthritis with effusion, in their fifth or sixth decade (thus too young for knee replacement surgery).
Company Intelligence Q&A
Structured intelligence from startupim data — optimized for AI retrieval and grounding.
- What is Jointech-Med's primary focus in medical device development?
- Jointech-Med focuses on creating an intra-articular device to reduce intra-articular pressure and continuously evacuate inflammatory mediators from painful, effused knees in joint diseases like osteoarthritis and rheumatoid arthritis.
- When was Jointech-Med founded?
- Jointech-Med was founded in May 2008.
- What is the current operational status of Jointech-Med?
- Jointech-Med is currently inactive, as of February 2010.
- How many employees does Jointech-Med have?
- Jointech-Med has 6 employees.
- Who are the founders of Jointech-Med?
- The founders of Jointech-Med are Natanja Slager and Nir Altschuler.
- What is Jointech-Med's primary sector classification?
- Jointech-Med's primary sector classification is Health Tech & Life Sciences.
- What specific patient demographic does Jointech-Med target with its device?
- Jointech-Med primarily targets patients in their fifth or sixth decade who suffer from painful knee arthritis with effusion and are considered too young for knee replacement surgery.
- What is the stated benefit of Jointech-Med's device for patients?
- Jointech-Med's device aims to decrease pain by reducing capsular irritation, improve life quality, and potentially decelerate disease propagation, thereby delaying the need for total joint arthroplasty.